Type to select a Country
The overall health of a vaccine market includes an assessment of the total number of suppliers, relative concentration among them, ability to distribute globally and the state of the development to quantify whether the market is healthy, concerning, or unhealthy. Measured globally, this indicator assesses the health of 12 vaccine markets.
Regular semi-quantitative assessments of individual market health will be conducted by partners on an annual basis to track level of market health over time, disaggregated by antigen and country typology (e.g., income level).
Level of health of the vaccine market—Global
Vaccine | 2019/2020 | 2021 |
---|---|---|
Bacille Calmette-Guerin (BCG)1 | Unhealthy | Unhealthy |
Human papillomavirus (HPV) | Unhealthy | Concerning |
Pneumococcal conjugate vaccine (PCV)2 | Concerning | Concerning |
Pneumococcal polysaccharide2 | Concerning | Concerning |
Measles | Concerning | Concerning |
Measles-rubella | Concerning | Concerning |
Measles-mumps-rubella (MMR)2 | Concerning | Concerning |
Penta (whole-cell pertussis-containing) | Healthy | Healthy |
Hexa (acellular pertussis-containing)2 | Unhealthy | Unhealthy |
Tetanus-diphtheria2 | Healthy | Healthy |
Inactivated polio vaccine, stand-alone | Healthy | Healthy |
Rotavirus | Healthy | Healthy |
1) No market study update in 2020 - same as 2019.
2) No market study update - same as 2020.
Unhealthy: the market does not have a stable and diverse supply
Concerning: the market has a significant concentration of supply with a potential for market disruption
Healthy: the market has a diverse and stable supplier base
1) UNICEF
2) WHO: via the MI4A initiative
3) Gavi Secretariat
4) BMGF